Variable mannose-binding lectin expression during postoperative acute-phase response

J W Olivier Van Till1, Marja A Boermeester, Piet W Modderman

  • 1Department of Surgery, Academic Medical Center Amsterdam, University of Amsterdam, The Netherlands.

Surgical Infections
|November 7, 2006
PubMed
Abstract

Insights

Low mannose-binding lectin (MBL) levels predict MBL expression during acute-phase responses. A baseline plasma MBL concentration of 0.5 µg/mL effectively identifies MBL gene variants, aiding in preoperative risk assessment for infections.

Area of Science:

  • Immunology
  • Genetics
  • Surgical Medicine

Background:

  • Low mannose-binding lectin (MBL) concentrations and genetic variations are linked to infectious complications.
  • MBL deficiency's role during surgery-induced acute-phase responses requires further investigation.

Purpose of the Study:

  • To investigate MBL expression and deficiency during an acute-phase response following surgery.
  • To determine if baseline MBL levels predict MBL expression post-surgery.
  • To assess the utility of a specific MBL plasma concentration cutoff for identifying MBL gene variants.

Main Methods:

  • Collected blood samples from 20 patients undergoing abdominal surgery (transhiatal esophagectomy) at multiple time points.
  • Measured plasma concentrations of MBL, C-reactive protein (CRP), and secretory phospholipase A2 (sPLA2).
  • Classified patients based on preoperative MBL levels (<0.5 or ≥0.5 µg/mL) and confirmed MBL deficiency via genetic sequencing.

Main Results:

  • Baseline MBL concentrations strongly correlated with maximal postoperative MBL levels (r = 0.88, p < 0.0001).
  • No significant correlation was observed between baseline and maximal concentrations for CRP or sPLA2.
  • Genetic variants in MBL alleles were found in 40% of patients, associated with lower MBL levels (p = 0.005).
  • A baseline MBL cutoff of 0.5 µg/mL demonstrated 100% sensitivity and 83% specificity in identifying exon-1 MBL variants.

Conclusions:

  • Preoperative plasma MBL concentration is a reliable predictor of MBL expression during the acute-phase response.
  • A baseline MBL cutoff of 0.5 µg/mL can identify patients with MBL exon-1 variants without genetic sequencing.
  • This simple method allows for preoperative identification of MBL-deficient patients at risk for infectious complications.